(Q43678384)

25 November 2017

title

Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigens (English)

1 reference

ORCID Public Data File 2021

25 November 2017

1 reference

author name string

Klinguer C

1

1 reference

25 November 2017

Beck A

2

1 reference

25 November 2017

De-Lys P

3

1 reference

25 November 2017

Bussat MC

4

1 reference

25 November 2017

Blaecke A

5

1 reference

25 November 2017

Derouet F

6

1 reference

25 November 2017

Bonnefoy JY

7

1 reference

25 November 2017

Nguyen TN

8

1 reference

25 November 2017

Corvaïa N

9

1 reference

25 November 2017

Velin D

10

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

19

1 reference

25 November 2017

issue

30

1 reference

25 November 2017

page(s)

4236-4244

1 reference

IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Single-dose antenatal tetanus immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Intranasal booster vaccination against diphtheria and tetanus in man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Intranasal vaccination: pharmaceutical evaluation of the vaccine delivery system and immunokinetic characteristics of the immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridges

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Protective and disease-enhancing immune responses to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

The enhancement of humoral and cellular immune responses by dimethyldioctadecylammonium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Immune functions and immunopathology of the mucosa of the upper respiratory pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

DDA as an immunological adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

Effects of immunological adjuvants on the mouse complement system--II. Anti-complementary effects of surface-active compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900156-6

7 January 2021

10.1016/S0264-410X(01)00156-6

Identifiers

DOI

1 reference

25 November 2017

1 reference